Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

L Hyrich, Kimme; D. Watson, K.; J. Silman, Alan; Symmons, Deborah; BSR Biologics Register, The

doi:10.1093/rheumatology/kel149

Public

Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

Published in Lara D. Veeken • May 16, 2006

Authors:

Kimme L Hyrich

K. D. Watson

Alan J. Silman

Abstract

BACKGROUND: Anti-tumour necrosis factor-alpha (TNF-alpha) therapies represent an important advancement in therapy for rheumatoid arthritis (RA). However, there remains a proportion of patients who do not improve despite therapy. These drugs are expensive and have the potential of serious toxicity. T...

Subject

Medicine

Etanercept

Rheumatoid arthritis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!